Keiko Baba

In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit

Takeshi Noshi, Mitsutaka Kitano, K. Taniguchi et al. · Antiviral Research · 2018 · 376 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza

Takeki Uehara, Frederick G. Hayden, Keiko Kawaguchi et al. · The Journal of Infectious Diseases · 2019 · 192 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16

Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study

Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari et al. · Clinical Infectious Diseases · 2022 · 155 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes

Nobuo Hirotsu, Hiroki Sakaguchi, Chisako Sato et al. · Clinical Infectious Diseases · 2019 · 153 citations · Full text

Medicine, Infectious Diseases, Pediatrics +13

A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part

Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari et al. · Antimicrobial Agents and Chemotherapy · 2022 · 136 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12